DaVita (NYSE:DVA) Lowered to Hold Rating by StockNews.com

DaVita (NYSE:DVA) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday.

DVA has been the topic of a number of other reports. Sanford C. Bernstein set a $184.00 price target on DaVita in a research note on Friday, February 21st. Barclays lifted their target price on shares of DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 18th. Finally, Cowen reiterated a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has assigned a buy rating to the company. According to MarketBeat, DaVita currently has an average rating of “Hold” and an average price target of $166.33.

DaVita Price Performance

Shares of NYSE DVA opened at $151.82 on Wednesday. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21. The stock has a market capitalization of $12.15 billion, a price-to-earnings ratio of 14.14, a PEG ratio of 1.07 and a beta of 0.99. The firm’s 50 day simple moving average is $156.77 and its 200-day simple moving average is $157.44. DaVita has a 12 month low of $125.64 and a 12 month high of $179.60.

DaVita (NYSE:DVA) last released its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. Analysts expect that DaVita will post 10.76 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. Copia Wealth Management purchased a new position in DaVita in the 4th quarter valued at approximately $30,000. SBI Securities Co. Ltd. purchased a new position in DaVita in the fourth quarter valued at $41,000. Coppell Advisory Solutions LLC grew its stake in DaVita by 50.0% during the 4th quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company’s stock worth $45,000 after purchasing an additional 100 shares in the last quarter. Canada Post Corp Registered Pension Plan purchased a new stake in DaVita during the 4th quarter worth about $55,000. Finally, Quarry LP acquired a new stake in DaVita in the 3rd quarter valued at about $60,000. Institutional investors and hedge funds own 90.12% of the company’s stock.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.